WILLIAM MCKINLEY: Open Payments
NPI 1326580820 · CARTHAGE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 21 payments from 5 companies in 2025. Trend: 2023 $288 · 2024 $175 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $197 |
| Novo Nordisk Inc | 5 | $96 |
| ABBVIE INC. | 3 | $45 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: AIRSUPRA, Ozempic, FARXIGA, UBRELVY, Rybelsus, TRELEGY ELLIPTA, VAXELIS.
Industry payments across MS — which companies pay providers there.
